Junshi Biosciences: The two shareholders plan to collectively reduce their holdings by no more than 2.09% of the shares.

Junshi Biology announced that Shanghai Tan Ying Fund plans to reduce its holdings by no more than 20,533,800 shares, accounting for less than 2% of the total share capital, through block trading from May 20 to August 19, 2026, due to the fund's term and liquidity arrangements. Ms. He Ming plans to reduce her holdings by no more than 882,600 shares, accounting for less than 0.086% of the total share capital, through concentrated bidding during the same period due to personal fund needs. The implementation of the two shareholders' reduction plans is subject to uncertainties and will not have a significant impact on the company's governance and operations.